https://www.cellectar.com/investors/sec-filings/annual-reports/xbrl_doc_only/145
Annual Reports :: Cellectar Biosciences, Inc. (CLRB)
annual reportsbiosciencesincclrb
https://convention.bio.org/participating-companies/cellectar-biosciences-inc
Cellectar Biosciences, Inc. - BIO International Convention 2026
bio international conventionbiosciencesinc
https://pharmaceuticaldaily.com/cellectar-biosciences-provides-strategic-update-on-clinical-development-pipeline-programs-and-corporate-restructuring/
Cellectar Biosciences Provides Strategic Update on Clinical Development, Pipeline Programs and...
Dec 11, 2024 - Evaluating strategic options for iopofosine I 131 a late-stage clinical program with compelling Phase 2 data and a substantial market opportunity Focusing on...
clinical development pipelinebiosciencesprovidesstrategicupdate
https://www.cmlviz.com/stocks/CLRB/pivot-points
CLRB Pivot Points, Technical Analysis and Moving Averages - Cellectar Biosciences Inc Technicals -...
Cellectar Biosciences Inc. pivot points and technical analysis for CLRB with key turning points and technical indicators as well as moving averages.
pivot pointstechnical analysis
https://healthcarewirehongkong.com/article/845658615-cellectar-biosciences-to-present-data-in-poster-presentation-at-the-american-association-for-cancer-research-special-conference-on-advances-in
Cellectar Biosciences to Present Data in Poster Presentation at the American Association for Cancer...